Icecure MedicalICCM -1.68%46 3-Year ROIIC % is 191.72 as of Dec. 2025. GuruFocus rates ICCM with a GF Score™ of 46/100 and a GF Value™ of $21.27 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 798 Medical Devices & Instruments companies, Icecure Medical ranks better than 93.23% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Icecure Medical's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 191.72%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Icecure Medical's 3-Year ROIIC % or its related term are showing as below:
ICCM's 3-Year ROIIC % is ranked better than 93.23% of 798
companies
in the Medical Devices & Instruments industry
Industry Median: 1.57
vs ICCM: 191.72
Icecure Medical (NAS:ICCM) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Icecure Medical 3-Year ROIIC % Related Terms
Icecure Medical 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Icecure Medical's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICCM vs LFWD, IRIX, GTHP: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Icecure Medical's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Icecure Medical 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Icecure Medical's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Icecure Medical's 3-Year ROIIC % falls into.
Icecure Medical's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -15.094 (Dec. 2025) - -16.739 (Dec. 2022) )
/
( 4.465 (Dec. 2025) - 3.607 (Dec. 2022) )
=
1.645
/
0.858
=
191.72%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Icecure Medical (ICCM) has a 3-Year ROIIC % of 191.72 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Icecure Medical and its competitors. According to the industry distribution chart, Icecure Medical ranks #54 out of 798 companies in the Medical Devices & Instruments industry, placing it in the top 6.8%.
Is Icecure Medical's 3-Year ROIIC % too high?
Icecure Medical's current 3-Year ROIIC % is 191.72. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.57. Icecure Medical's value of 191.72 is 12111.5% above this industry median. Based on the distribution chart, Icecure Medical ranks #54 out of 798 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Icecure Medical has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Icecure Medical's 3-Year ROIIC % compare to LFWD and IRIX?
According to the Medical Devices & Instruments industry distribution chart, Icecure Medical ranks #54 out of 798 companies for 3-Year ROIIC %. This places Icecure Medical in the top 7% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.57. Icecure Medical's value of 191.72 is 12111.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.57, based on 798 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Icecure Medical's current 3-Year ROIIC % of 191.72 is 12111.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Icecure Medical and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Icecure Medical's current 3-Year ROIIC % is 191.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icecure Medical stock overvalued right now?
Based on GuruFocus' analysis, Icecure Medical (ICCM) is currently considered Possible Value Trap. The stock's GF Value™ is $21.27, compared to a current price of $4.09 — trading 80.8% below its estimated fair value. The current 3-Year ROIIC % is 191.72 and 12111.5% above the Medical Devices & Instruments industry median of 1.57. Icecure Medical's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Icecure Medical (ICCM), the current 3-Year ROIIC % is 191.72 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Icecure Medical (ICCM) Overvalued in 2026?
Based on GuruFocus' analysis, Icecure Medical stock appears to be undervalued.
The current stock price of $4.09 is trading 80.8% below its estimated GF Value™ of $21.27.
GuruFocus considers Icecure Medical to be Possible Value Trap.
Key valuation signals for ICCM:
3-Year ROIIC %: 191.72
GF Value™: $21.27 vs. price of $4.09 (80.8% below fair value)
Industry Position: 12111.5% above the Medical Devices & Instruments median (#54 of 798)
No single metric tells the full story. See the ICCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
46GF Score
Get the complete analysis for ICCM
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICCM has been successfully added to your 
